Dr. Céline Bellenguez of Lille University Hospital recently led a significant meta-analysis examining the genetic architecture of Alzheimer’s disease and related dementias. By investigating large datasets of individuals of European ancestry, the research identified 91 genetic loci linked to disease risk. This includes 16 novel sites, providing a clearer view of the biological pathways involved in neurodegeneration.
While the APOE gene remains the most well-known risk factor, these findings demonstrate that the genetic roots of dementia are far more complex. The study implicates various biological processes, including lipid metabolism, immune system response, and endosome function. These insights provide researchers with concrete targets for future studies, as they work to untangle the mechanisms that lead to clinical dementia symptoms.
Despite these advancements, Dr. Bellenguez notes that these discoveries do not yet offer direct tools for routine clinical diagnosis. Current polygenic risk scores remain limited in their ability to predict outcomes for individual patients. The findings serve primarily as a foundation for basic research rather than immediate bedside application. The goal remains to identify specific causal variants that can eventually lead to better drug development and more precise diagnostic markers.
A major takeaway from the research is the need for more inclusive data. The current study focuses on European populations, but Dr. Bellenguez emphasizes that genetic risk can vary significantly across different ancestry groups. Expanding these studies to be more diverse is necessary for the development of equitable precision medicine. Moving forward, the research team intends to look at how these genetic factors interact with other environmental and life-style variables to better inform prevention and treatment strategies.